Feasibility of Integrating Local Vibration Into Rehabilitation of Elderly Patients After Hip Fracture

NCT ID: NCT07309965

Last Updated: 2025-12-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

25 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-11-19

Study Completion Date

2026-12-19

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Fractures of the upper end of the femur in elderly patients are the 2nd most common fracture.

A fracture leads to a syndrome of psychomotor maladjustment, encouraged by pain and aggravated by hospitalisation. In 2014, 50,000 women and 16,000 men suffered this type of fracture every year. The consequences are serious, with a one-year mortality rate of 20 to 24% and an institutionalisation rate of 25%. In 2015, the direct cost of hip fracture in France was estimated at around €1 billion.

In line with the recommendations of the National Institute for Health and Care Excellence (NICE) and the results of meta-analyses, it is recommended that, in the absence of surgical or medical contraindications, patients should be assessed within 24 hours of hip fracture surgery, with a view to initiating early mobilisation and multidisciplinary rehabilitation.

It has been shown in healthy subjects that prolonged application of localised vibrations optimises nerve capacity, leading to an increase in maximum voluntary force.

For population of frail elderly post-operative patients, this localised vibration technique could accelerate and improve functional recovery, particularly in terms of muscle strength, joint mobility and pain. A reduction in muscle loss is hoped for, with benefits in terms of tolerance compared with neurostimulation.

As part of the implementation of the above-mentioned recommendations, we wish to assess the quality of the integration of this technique, already in use in the department on an ad hoc basis, into the organisation of the department and of the patient's care pathway as a complement to the rehabilitation protocols, by identifying the obstacles and facilitating factors. The study will also provide the first estimates of the effect on muscle recovery.

The investigator hypothesise that this local vibration protocol can be integrated into the rehabilitation department's work schedule and into the patient's care pathway, and that it will be acceptable to both the patient and the nursing staff.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Fracture Femur Elderly

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Rehabilitation Fracture of the upper end of the femur Local muscle vibration Geriatrics

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

A single-centre, prospective feasibility study
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Subjects aged 75 and over with surgery following a fracture of the upper end of the femur

Patient, aged 75 and over, hospitalised in Medical and Rehabilitation Care no later than D14 of his operation for a fracture of the upper end of the femur

Group Type EXPERIMENTAL

Initial Assessment

Intervention Type DIAGNOSTIC_TEST

Upon entering the SMR service, the patient receives several evaluations from the nurse.

* a functional assessment :

* Basic ADLs (BADLs) 6-point score
* Instrumental ADLs (IADLs) 8-point score
* a frailty assessment
* a nutritional assessment

* Body Mass Index (BMI)
* Bioelectrical Impedance Analysis
* JAMAR Grip Strength Test
* A measurement of the maximum isometric strength of the non-injured limb (T0)
* An assessment of physical performance using the Short Physical Performance Battery (SPPB)
* An assessment of the risk of falling using TINETTI

It has two subscales:

* Balance section (maximum 16 points) Assesses sitting balance, sit-to-stand, standing balance, response to mild pushes, turning, etc.
* Gait section (maximum 12 points) - Pain assessment using a simple verbal scale (EVS)

Standard rehabilitation programme combined with local vibration sessions

Intervention Type DEVICE

The patient will receive a standard rehabilitation programme combined with local vibration sessions 5 times a week for 30 minutes each for 4 weeks.

A record of these sessions will be completed every day by the rehabilitation specialist.

Final assessment

Intervention Type OTHER

The patient will undergo the same tests as the initial assessment, with the addition of a measurement of the isometric force on the injured limb (T1).

Acceptability and satisfaction questionnaire

Intervention Type OTHER

An acceptability and satisfaction questionnaire will be given to all the paramedical teams and patients who took part in the study in order to assess the potential constraints linked to the implementation.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Initial Assessment

Upon entering the SMR service, the patient receives several evaluations from the nurse.

* a functional assessment :

* Basic ADLs (BADLs) 6-point score
* Instrumental ADLs (IADLs) 8-point score
* a frailty assessment
* a nutritional assessment

* Body Mass Index (BMI)
* Bioelectrical Impedance Analysis
* JAMAR Grip Strength Test
* A measurement of the maximum isometric strength of the non-injured limb (T0)
* An assessment of physical performance using the Short Physical Performance Battery (SPPB)
* An assessment of the risk of falling using TINETTI

It has two subscales:

* Balance section (maximum 16 points) Assesses sitting balance, sit-to-stand, standing balance, response to mild pushes, turning, etc.
* Gait section (maximum 12 points) - Pain assessment using a simple verbal scale (EVS)

Intervention Type DIAGNOSTIC_TEST

Standard rehabilitation programme combined with local vibration sessions

The patient will receive a standard rehabilitation programme combined with local vibration sessions 5 times a week for 30 minutes each for 4 weeks.

A record of these sessions will be completed every day by the rehabilitation specialist.

Intervention Type DEVICE

Final assessment

The patient will undergo the same tests as the initial assessment, with the addition of a measurement of the isometric force on the injured limb (T1).

Intervention Type OTHER

Acceptability and satisfaction questionnaire

An acceptability and satisfaction questionnaire will be given to all the paramedical teams and patients who took part in the study in order to assess the potential constraints linked to the implementation.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients aged 75 or over who have undergone surgery for a fracture of the upper end of the femur
* Hospitalised in the SMR department no later than D14 of their operation
* Resource Iso Group greater than or equal to 3 on the Aggir scale
* Patient capable of consenting who has signed a consent form or patient unable to express consent at the discretion of the principal investigator, informed and not opposed to the study, for whom a trusted person, or if not available, the family, or if not available, a close relative has signed an informed consent within a maximum of 2 days. For patients under guardianship, the guardian's consent will be requested, and for patients under curatorship, the patient will sign the consent in the presence of the curator within a maximum of 2 days as well.
* Affiliated to a social security scheme

Exclusion Criteria

* Persons deprived of their liberty by a judicial or administrative decision
* Individuals with severe psycho-behavioral disorders (major psychiatric or neurocognitive disorders)
* Persons admitted to a health or social establishment for purposes other than research
* Contraindications to electrical stimulation:

* Patient with active devices such as pacemakers, defibrillators, insulin pumps, neurostimulators, etc
* Patient with phlebitis or risk of thrombosis
* Epileptic patient
* Patient with fragile skin or open wounds on the lower limbs
* Subject participating in another interventional study with an exclusion period still in progress at pre-inclusion.
Minimum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hospices Civils de Lyon

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

HOPITAL PIERRE GARRAUD - Service de MEDECINE GERIATRIQUE

Lyon, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Alexandre MENDIBIL, MD

Role: CONTACT

Phone: 00 33 4 72 16 71 39

Email: [email protected]

Stéphanie TRIPOZ DIT MASSON

Role: CONTACT

Phone: 00 33 4 78 86 32 92

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Alexandre MENDIBIL, MD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

69HCL24_1080

Identifier Type: -

Identifier Source: org_study_id